Blood-sugar-reducing composition and application thereof

Abstract

The invention discloses a blood-sugar-reducing composition and application thereof. In the blood-sugar-reducing composition, insulin and selenium are combined according to an insulin-selenium ratio of 1U:(1-40mu g).In the blood-sugar-reducing composition, the insulin and selenium are subjected to compound combination, and the antioxidation action and the insulin-like action of the selenium further provide a foundation for the reasonable compound combination of the insulin and selenium. The compound composition can reduce the blood sugar level of a diabetic, and the blood sugar concentration can be reduced to about 80% two hours after the composition is taken, wherein the insulin has more obvious blood-sugar-reducing action, thereby being the main drug; and sodium selenite has less action in comparison with the insulin, thereby being the adjuvant drug. The combination of the selenium and the insulin can reduce the dose of the insulin, and the combination has a better curative effect in comparison with the single use of the insulin.

Description

technical field [0001] The invention belongs to the technical field of prevention and treatment of diabetes, and relates to a composition for lowering blood sugar and an application thereof. Background technique [0002] 1. Overview of diabetes [0003] Diabetes mellitus (DM) is a metabolic disease characterized by elevated blood sugar due to absolute or relative insufficiency of insulin secretion, including type 1 diabetes and type 2 diabetes. Type 2 diabetes (T2DM) accounts for more than 90% of the total number of diabetes, and type 2 diabetes and its complications are spreading globally. According to WHO estimates, by 2025, the number of diabetic patients in the world will reach 300 million, twice the incidence rate in 1995, suggesting that diabetes will become a serious burden on medical resources in the near future. [0004] The ability to produce insulin in patients with type 2 diabetes is not completely lost, and some patients even produce too much insulin, but the ...

AI Technical Summary

Problems solved by technology

[0004] The ability to produce insulin in patients with type 2 diabetes is not completely lost, and some patients even produce too much insulin, but the effect of insulin is greatly reduced, so the insulin in the patient's body is in a state of relative deficiency

Its antioxidant function and insulin-like effect have made the relationship between selenium and insulin resistance in diabetes a research hotspot, and selenium may be used as an alternative drug for diabetes combination drugs; but so far there has been no report on the use of selenium preparations alone in the treatment of diabetes

Images